HBCP vs CARE

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 22, 2026

HBCP

40.8
AI Score
VS
CARE Wins

CARE

63.4
AI Score

Investment Advisor Scores

HBCP

41score
Recommendation
HOLD

CARE

63score
Recommendation
STRONG BUY

AI Analyst Insights

Detailed Metrics Comparison

Metric HBCP CARE Winner
Forward P/E 9.3985 13.6612 HBCP
PEG Ratio 0 0 Tie
Revenue Growth 2.7% 68.3% CARE
Earnings Growth -19.5% 253.9% CARE
Tradestie Score 40.8/100 63.4/100 CARE
Profit Margin 29.1% 44.9% CARE
Beta 1.00 1.00 Tie
AI Recommendation HOLD STRONG BUY CARE

Relative Price Performance (Last 90 Days)

HBCP 1M: -12.2% · 3M: -13.7% CARE 1M: +0.3% · 3M: -10.4%

Current Technical Phase

HBCP

Markdown
Sell / avoid

Price below a falling SMA50 (slope -2.8%), weak momentum, RSI 22

RSI (14): 22.2 · Price: $59.80

CARE

Distribution
Trim / tighten stop

Price near a flattening SMA50 (slope -4.3%) with fading momentum, RSI 49

RSI (14): 49.0 · Price: $30.37

Fundamentals Snapshot

Metric HBCP CARE
Market Cap — —
Forward P/E 9.7 11.7
Trailing P/E 10.5 5.2
Revenue (TTM) — —
Revenue Growth 0.0% 0.7%
Gross Margin 1.0% 1.0%
Operating Margin 0.4% 0.6%
EPS 5.67 5.80
Dividend Yield 0.02% 0.00%

Frequently Asked Questions

Based on our detailed analysis, CARE is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.